Drug Information Association Logo
« Back to Listing

New Approaches to International Collaboration Between Regulators (Part 2 of 2)

Track:
Global Regulatory

Day & Time:
June 16, 11:00AM - 12:30PM (Pacific Standard Time)

Session Number:
144

Room Number:
6F

Level:
Intermediate

Type:
Forum

Title:
New Approaches to International Collaboration Between Regulators (Part 2 of 2)

Chair(s):
Murray M. Lumpkin, MD, MSc
Deputy Director, Regulatory Affairs, Global Health and Integrated Development
Bill and Melinda Gates Foundation, United States

Description:
Building on Part 1, that explored how the model of regulatory collaboration has evolved from traditional harmonization and information sharing models to strategic coalitions and work-sharing initiatives, this part 2 forum will discuss regulatory collaboration efforts in a wider international context and with a wider group of regulators. The specific role of WHO and non- governmental organizations will also be addressed.

Part 1 will take place on Monday at 8:30 AM (Session #121).

Learning Objective(s):
Discuss the current challenges facing international regulators including how this impacts the pharmaceutical industry and patients; Describe emerging international initiatives.

Presentation(s) & Speaker(s):
Panelist
Emer Cooke, MBA
Head of International Affairs
European Medicines Agency, European Union, United Kingdom

Panelist
John Skerritt, PhD
National Manager
Therapeutic Goods Administration (TGA), Australia

Panelist
Aiping Zhang
Inspector General, Department of Drug and Cosmetics Supervision
China Food and Drug Administration (CFDA), China

Panelist
Lembit Rago, MD, PhD
Head, Regulation of Medicines and other Health Technologies
World Health Organization (WHO), Switzerland

Panelist
Jaime César de Moura Oliveira, LLM
Director
Agência Nacional De Vigilância Sanitária (ANVISA), Brazil